Conversion of 96,287 warrants into 96,287 equity shares of face value of Rs. 10/- each.
Trident Texofab Ltd. Press Release May 26 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Trident Texofab
- Outcome Of Board Meeting Held On May 26, 2025
- Board Meeting Outcome for Outcome Of Board Meeting Held On May 26, 2025
- Trident Texofab Ltd. Press Release May 21 2025
- Board Meeting Intimation for Considering And Approving The Audited Financial Result For Quarter And Year Ended On 31.03.2025
- Trident Texofab Ltd. Press Release May 14 2025
Later from Trident Texofab
- Board Meeting Outcome for Outcome Of Board Meeting Held On May 29, 2025
- Result-Financial Result For The Quarter And Year Ended On March 31, 2025
- Appointment Of Internal Auditor
- Announcement under Regulation 30 (LODR)-Conversion of Securities
- Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31.03.2025
Follow Trident Texofab into a list and get an email when it puts out news.
Follow Trident Texofab